iNtRON Biotechnology Revenue and Competitors
Estimated Revenue & Valuation
- iNtRON Biotechnology's estimated annual revenue is currently $4.8M per year.
- iNtRON Biotechnology's estimated revenue per employee is $155,000
Employee Data
- iNtRON Biotechnology has 31 Employees.
- iNtRON Biotechnology grew their employee count by -9% last year.
iNtRON Biotechnology's People
| Name | Title | Email/Phone |
|---|
iNtRON Biotechnology Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.8M | 31 | -9% | N/A | N/A |
What Is iNtRON Biotechnology?
iNtRON Biotechnology (An ISO 13485, ISO9001 & ISO14001 certified company) is today revolutionizing the world of PCR assays by developing and producing quality iNNOPLEX™ Detection Kits. iNNOPLEX™ is an innovative system for infectious organisms identification. This system is developed with ‘innovative thinking’ and ‘convenient process for customers’. From preparing the samples to check the result iNNOPLEX™ system shows the fastest, the convenient and the reliable results. iNNOPLEX™ system, the most trusted system in pathogen identification. As a world market leading innovator, developer and producer of Molecular Diagnostic assays based on Real-time PCR and Multiplex PCR, iNtRON Biotechnology is striving to be world innovator in the market segment. We are very proud of what we have achieved from our Research & Development. All the assays we are currently producing and selling have been designed in house and our Research and Development team has done an excellent job by optimizing and validating the assays in house which are proving out to be exceptional on the marketplace.
keywords:N/A
N/A
Total Funding
31
Number of Employees
$4.8M
Revenue (est)
-9%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Seongnam
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $7.2M | 55 | 6% | N/A |
#2 | $7.3M | 62 | -3% | N/A |
#3 | $18.1M | 72 | -6% | N/A |
#4 | $159.5M | 858 | 8% | $200M |
#5 | $24480000M | 8668 | N/A | N/A |